Japanese journal of clinical oncology
Prognostic impact of intraductal carcinoma of the prostate and PTEN loss in metastatic castration-sensitive prostate cancer treated with androgen receptor pathway inhibitors.
Shun Sato, Fumihiko Urabe, Yuya Iwamoto, Kosuke Iwatani, Yu Imai, Kojiro Tashiro, Miyaka Umemori, Jun Miki, Masayuki Shimoda, Takahiro Kimura, Hiroyuki Takahashi
Published: 202610.1093/jjco/hyaf214
Abstract
BACKGROUND: Intraductal carcinoma of the prostate (IDC-P) and phosphatase and tensin homolog (PTEN) alteration are established adverse features in prostate cancer. However, their coexistence and prognostic relevance in the era of androgen receptor pa…
Preview only. Read the full abstract at the source